Colm Cunningham, Ph.D.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Exalys Therapeutics
    Topic: 
    Post-operative cognitive dysfunction
    Date added: 
    05/19/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    06/14/2023
    Date reviewed: 
    06/02/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    IONIS Therapeutics
    Topic: 
    Microglial activation and delirium
    Date added: 
    05/19/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    06/14/2023
    Date reviewed: 
    06/02/2023
Return to 0042_ADS_13th Annual Conference of the American Delirium Society_Live